Cogent Biosciences, Inc. (COGT) › Total LiabilitiesCogent Biosciences, Inc. (COGT) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $20.81M2018: $25.69M2019: $17.66M2020: $16.25M2021: $17.91M2022: $45.08M2023: $55.63M2024: $71.61M2025: $301.24M$301.24M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$301.24M+320.7%2024$71.61M+28.7%2023$55.63M+23.4%2022$45.08M+151.7%2021$17.91M+10.2%2020$16.25M-8.0%2019$17.66M-31.3%2018$25.69M+23.5%2017$20.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share